Ncardia Launches iPSC-Based Phenotypic Screening Service to Bring Human Disease Biology Earlier into Drug Discovery and Development

Ncardia, a leading provider of human iPSCderived cell-based assays and services for drug discovery and development, announced the launch of their DiscoverHIT drug screening platform. The new service enables researchers to access human disease-relevant biology earlier in the drug discovery process with the goal of bringing better medicines to patients faster.  For more infomration please find the press release here.

Read more

InhaTarget is looking for a COO

InhaTarget Therapeutics, a spin-off of ULB, specialized in the development of innovative and targeted dry powders for inhalation (DPI) is looking for a Chief Operation Officer. Interested? Please find the job offering and contact details here.

Read more